Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.71 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.71 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.71 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.71 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.71 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.71 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.71 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13337972 | 1.00 | HSD17B10 (0.71) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL29520844 | 0.95 | HSD17B10 (0.67) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL3615621 | 0.95 | HSD17B10 (0.67) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL13366510 | 0.94 | HSD17B10 (0.63) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL2418156 | 0.90 | HSD17B10 (0.74) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL13337971 | 0.90 | HSD17B10 (0.74) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL2418158 | 0.90 | HSD17B10 (0.74) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL24943563 | 0.88 | HSD17B10 (0.71) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL14495336 | 0.88 | HSD17B10 (0.71) | HSD17B10ALOX15PDK1PDK2PDK3 | |
| SCHEMBL770009 | 0.88 | HSD17B10 (0.71) | HSD17B10ALOX15PDK1PDK2PDK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120018853-A | Methods and absorbent articles for inhibiting fecal protease activity | 金伯利-克拉克环球有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-118001184-A | Surfactant for oily cosmetics | 理研维他命株式会社 | 2024-05-10 | — | — | CN | disclosed |
| US-20230265268-A1 | THERMOPLASTIC ELASTOMER COMPOSITION | POLYMAX THERMOPLASTIC ELASTOMERS, LLC | 2023-08-24 | — | — | US | disclosed |
| US-20230157299-A1 | DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION | KISMET TECHNOLOGIES INC. | 2023-05-25 | — | — | US | disclosed |
| US-11608450-B2 | Process for a continuous reaction with feedstocks derived from Bio-Renewable resources | Kraton Corporation (US) | 2023-03-21 | — | — | US | disclosed |
| EP-4125364-A1 | DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION | University of Central Florida Research Foundation, Inc. (US) | 2023-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157299-A1 | DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION | DSTN, CD63, EXOSC9 | HSD17B10 3750/4885ALOX15 1802/4885PDK1 4294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.